Cuu Long Pharmaceutical JSC (HOSE:DCL)

Vietnam flag Vietnam · Delayed Price · Currency is VND
55,100
-2,300 (-4.01%)
At close: Feb 27, 2026
130.54%
Market Cap 4.02T
Revenue (ttm) 1.32T
Net Income (ttm) 19.52B
Shares Out 73.04M
EPS (ttm) 267.00
PE Ratio 206.37
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 391,186
Average Volume 454,856
Open 57,500
Previous Close 57,400
Day's Range 53,400 - 57,500
52-Week Range 19,000 - 58,200
Beta 0.73
RSI 55.70
Earnings Date Apr 29, 2026

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, nervous system, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, phar... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 880
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DCL
Full Company Profile

Financial Performance

In 2025, HOSE:DCL's revenue was 1.32 trillion, an increase of 1.13% compared to the previous year's 1.31 trillion. Earnings were 19.52 billion, a decrease of -63.57%.

Financial Statements

News

There is no news available yet.